- Home
- CELU vs MNDO Comparison
CELU vs MNDO Comparison
Compare CELU & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- MNDO
- Stock Information
- Founded
- CELU 2016
- MNDO 1995
- Country
- CELU United States
- MNDO Israel
- Employees
- CELU N/A
- MNDO N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- CELU Health Care
- MNDO Technology
- Exchange
- CELU Nasdaq
- MNDO Nasdaq
- Market Cap
- CELU 42.2M
- MNDO 40.8M
- IPO Year
- CELU N/A
- MNDO 2000
- Fundamental
- Price
- CELU $1.37
- MNDO $1.68
- Analyst Decision
- CELU
- MNDO
- Analyst Count
- CELU 0
- MNDO 0
- Target Price
- CELU N/A
- MNDO N/A
- AVG Volume (30 Days)
- CELU 97.9K
- MNDO 139.8K
- Earning Date
- CELU 12-06-2024
- MNDO 05-07-2025
- Dividend Yield
- CELU N/A
- MNDO 12.65%
- EPS Growth
- CELU N/A
- MNDO N/A
- EPS
- CELU N/A
- MNDO 0.22
- Revenue
- CELU $48,200,000.00
- MNDO $21,446,000.00
- Revenue This Year
- CELU N/A
- MNDO N/A
- Revenue Next Year
- CELU $233.89
- MNDO N/A
- P/E Ratio
- CELU N/A
- MNDO $8.02
- Revenue Growth
- CELU 225.94
- MNDO N/A
- 52 Week Low
- CELU $1.00
- MNDO $1.70
- 52 Week High
- CELU $5.69
- MNDO $2.13
- Technical
- Relative Strength Index (RSI)
- CELU 40.70
- MNDO 30.74
- Support Level
- CELU $1.64
- MNDO $1.75
- Resistance Level
- CELU $2.40
- MNDO $2.12
- Average True Range (ATR)
- CELU 0.20
- MNDO 0.07
- MACD
- CELU -0.02
- MNDO -0.02
- Stochastic Oscillator
- CELU 0.00
- MNDO 0.90
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.